Cargando…
Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma
Metabolomics analysis possibly identifies new therapeutic targets in treatment resistance by measuring changes in metabolites accompanying cancer progression. We previously conducted a global metabolomics (G-Met) study of renal cell carcinoma (RCC) and identified metabolites that may be involved in...
Autores principales: | Sato, Tomonori, Kawasaki, Yoshihide, Maekawa, Masamitsu, Takasaki, Shinya, Morozumi, Kento, Sato, Masahiko, Shimada, Shuichi, Kawamorita, Naoki, Yamashita, Shinichi, Mitsuzuka, Koji, Mano, Nariyasu, Ito, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821950/ https://www.ncbi.nlm.nih.gov/pubmed/33374949 http://dx.doi.org/10.3390/metabo11010001 |
Ejemplares similares
-
Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma
por: Sato, Tomonori, et al.
Publicado: (2020) -
Predictive model for recurrence of renal cell carcinoma by comparing pre‐ and postoperative urinary metabolite concentrations
por: Morozumi, Kento, et al.
Publicado: (2021) -
Severe toxicity induced by accumulation of active sunitinib metabolite in a Japanese patient with renal cell carcinoma: a case report
por: Takasaki, Shinya, et al.
Publicado: (2017) -
High throughput LC/ESI-MS/MS method for simultaneous analysis of 20 oral molecular-targeted anticancer drugs and the active metabolite of sunitinib in human plasma
por: Hirasawa, Tensei, et al.
Publicado: (2023) -
Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report
por: Katsumata, Yuki, et al.
Publicado: (2021)